Tempus AI slips as Jefferies underperform call keeps pressure ahead of May earnings
Tempus AI shares fell as investors digested a fresh bearish initiation from Jefferies with a $35 price target issued on April 13, 2026, keeping pressure on sentiment. The stock’s pullback also comes as traders position ahead of the next earnings report expected in early May 2026.
1. What’s moving the stock
Tempus AI (TEM) traded lower Tuesday as a recent negative analyst initiation continued to weigh on the name. Jefferies initiated coverage on April 13, 2026 with an Underperform rating and a $35 price target, flagging concerns about the investment required for MRD and the upside profile versus peers, which has helped cap rallies and encouraged profit-taking on strength. (investing.com)
2. Why the timing matters now
The pullback comes with the next earnings catalyst approaching; multiple market calendars peg Tempus’ next report in early May 2026, which can increase positioning-driven volatility as traders de-risk into the event. With TEM already prone to sharp swings, even a modest risk-off tape can amplify declines when sentiment is fragile. (marketbeat.com)
3. What investors are watching next
Bulls are focused on whether biopharma collaboration momentum translates into clearer, monetizable contributions to growth and margins, following Tempus’ recently announced expanded oncology R&D collaboration with Gilead. Bears remain focused on valuation, cash burn, and the cost to scale newer initiatives, particularly if the company’s outlook does not materially exceed expectations. (biospace.com)